Altimmune, Inc. (ALT) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $5 thousand versus the consensus estimate of $2.14 thousand.
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Simmons First National Corp (SFNC) Misses Q2 EPS by 2c
- Private Bancorp of America, Inc. (PBAM) Tops Q2 EPS by 26c
- FingerMotion, Inc. (FNGR) Reports Q1 Loss of $0.03
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
